Home › Funds › BlackRock Inc › ALGS
BlackRock Inc position in ALGS
ALIGOS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)30.29K sh
Reported value held$174.78K
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 9.07K | $78.52K | New |
| Q4 2024 | 13.72K | $546.64K | Add |
| Q1 2025 | 13.04K | $107.58K | Reduce |
| Q2 2025 | 13.04K | $94.02K | Hold |
| Q3 2025 | 13.04K | $127.79K | Hold |
| Q4 2025 | 13.04K | $121.53K | Hold |
| Q1 2026 | 13.04K | $96.89K | Hold |
| Q2 2026 | 30.29K | $174.78K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALGS
- Vanguard Group 200.40K sh · $1.87M · Q4 2025
- Marshall Wace 246.58K sh · $1.42M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 76.25K sh · $439.94K · Q2 2026
- D. E. Shaw & Co 66.46K sh · $383.49K · Q2 2026
- UBS Group AG 59.99K sh · $346.12K · Q2 2026
- Geode Capital Management 47.17K sh · $272.32K · Q2 2026
- Renaissance Technologies 10.80K sh · $62.32K · Q2 2026
- Citigroup Inc 1.81K sh · $10.43K · Q2 2026
- JPMorgan Chase & Co 344 sh · $1.87K · Q2 2026
- Morgan Stanley 204 sh · $1.18K · Q2 2026
- Wells Fargo & Co 100 sh · $577 · Q2 2026